Biotin
Hypothyroidism and Wegovy: Safety, Monitoring, and Management Guidance Hypothyroidism and Wegovy can be safely combined in most cases, provided your thyroid condition is well-controlled with levothyroxine
But It comes with significantly higher discontinuation rates A concerning rate of dysesthesia And potential cardiac safety issues that require further investigation The headline 28.7% weight loss is impressive but the real-world difference vs tirzepatide is only about 3% , and side effects may be more pronounced
The TRIUMPH-4 Phase 3 data at 68 weeks showed 28.7% average weight loss, confirming that extended treatment does yield additional benefit
Ask about: Which medication class your provider recommends given your specific situation What your insurance covers and what the out-of-pocket costs will be What monitoring will be required (blood work, pregnancy tests, heart rate checks) What the plan is if the first medication does not work How long treatment should continue SeekPeptides members access comprehensive medication comparison tools, detailed protocol guides, and community discussions that help inform these conversations with healthcare providers
Once reconstituted for research, it is kept at 28 C and typically used within 28 days